ESR1 and metabolic dysfunction-associated steatotic liver disease: Recent evidence indicates that metabolic disturbances associated with NAFLD may affect the expression and activity of estrogen receptors in the endometrium, thereby potentially enhancing estrogen-mediated proliferative signaling [50].